Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-03-14

Clinical Trial Update: Peripheral Blood Mononuclear Cell (PBMC) Gene Expression in HCV Genotype 1 Patients [Phase 4]

View source ↗

Summary

A Phase 4 study examining peripheral blood mononuclear cell gene expression in genotype 1 hepatitis C patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED